Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study
Kudrimoti, Mahesh, Curtis, Amarintha, Azawi, Samar, Worden, Francis, Katz, Sanford, Adkins, Douglas, Bonomi, Marcelo, Elder, Jenna, Sonis, Stephen T., Straube, Richard, Donini, OreolaVolume:
239
Language:
english
Journal:
Journal of Biotechnology
DOI:
10.1016/j.jbiotec.2016.10.010
Date:
December, 2016
File:
PDF, 1.55 MB
english, 2016